Carlson RW - Search Results

1

Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Sachdev J, Smith ML, Somlo G, Ward JH, Wolff AC, Zellars R; National Comprehensive Cancer Network. Carlson RW, et al. J Natl Compr Canc Netw. 2011 Feb;9(2):136-222. doi: 10.6004/jnccn.2011.0016. J Natl Compr Canc Netw. 2011. PMID: 21310842 No abstract available.

2

Sequencing of endocrine therapies in breast cancer--integration of recent data.

Carlson RW. Carlson RW. Breast Cancer Res Treat. 2002 Oct;75 Suppl 1:S27-32; discussion S33-5. doi: 10.1023/a:1020361700012. Breast Cancer Res Treat. 2002. PMID: 12353821 Review.

3

The role of aromatase inhibitors in early breast cancer.

Chung CT, Carlson RW. Chung CT, et al. Among authors: carlson rw. Curr Treat Options Oncol. 2003 Apr;4(2):133-40. doi: 10.1007/s11864-003-0014-y. Curr Treat Options Oncol. 2003. PMID: 12594939 Review.

4

Overview of breast health care guidelines for countries with limited resources.

Anderson BO, Braun S, Carlson RW, Gralow JR, Lagios MD, Lehman C, Schwartsmann G, Vargas HI. Anderson BO, et al. Among authors: carlson rw. Breast J. 2003 May-Jun;9 Suppl 2:S42-50. doi: 10.1046/j.1524-4741.9.s2.3.x. Breast J. 2003. PMID: 12713496 Review.

5

Treatment of breast cancer in countries with limited resources.

Carlson RW, Anderson BO, Chopra R, Eniu AE, Jakesz R, Love RR, Masetti R, Schwartsmann G; Global Summit Treatment Panel. Carlson RW, et al. Breast J. 2003 May-Jun;9 Suppl 2:S67-74. doi: 10.1046/j.1524-4741.9.s2.6.x. Breast J. 2003. PMID: 12713499

6

A roundtable discussion of aromatase inhibitors as therapy for breast cancer.

Allred DC, Baum M, Buzdar AU, Carlson RW, Dowsett M, Elledge RM, Gradishar WJ, Grana G, Howell A, Mamounas EP. Allred DC, et al. Among authors: carlson rw. Breast J. 2003 May-Jun;9(3):213-22. doi: 10.1046/j.1524-4741.2003.09305.x. Breast J. 2003. PMID: 12752630 Review.

7

Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.

Carlson RW, Henderson IC. Carlson RW, et al. Breast Cancer Res Treat. 2003;80 Suppl 1:S19-26; discussion S27-8. doi: 10.1023/a:1025459232293. Breast Cancer Res Treat. 2003. PMID: 14535531 Review.

8

Goals and objectives in the management of metastatic breast cancer.

Chung CT, Carlson RW. Chung CT, et al. Among authors: carlson rw. Oncologist. 2003;8(6):514-20. doi: 10.1634/theoncologist.8-6-514. Oncologist. 2003. PMID: 14657529 Free article. Review.

9

Phase I trial of uracil-ftorafur, leucovorin, and etoposide: an active all-oral regimen for metastatic breast cancer.

Hartman AR, Grekowicz A, Lum BL, Carlson RW, Schurman C, Sikic BI, Shapiro R, Stockdale FE. Hartman AR, et al. Among authors: carlson rw. Breast Cancer Res Treat. 2003 Nov;82(1):61-9. doi: 10.1023/B:BREA.0000003920.27391.ac. Breast Cancer Res Treat. 2003. PMID: 14672404 Clinical Trial.

10

High-dose chemotherapy and stem cell transplantation does not improve relapse-free or overall survival in women with high-risk breast cancer.

Carlson RW, Wheatley K. Carlson RW, et al. Cancer Treat Rev. 2004 Feb;30(1):131-7. doi: 10.1016/j.ctrv.2003.11.007. Cancer Treat Rev. 2004. PMID: 14766131 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

549 results

Search Page